Canara HSBC Life Insurance FY26 Results: PAT ₹1,266 mn, Analyst Meet Audio Available
Canara HSBC Life Insurance reported audited FY26 results with PAT of ₹1,266 mn, VNB of ₹6,273 mn (22.4% margin), and Embedded Value of ₹72,333 mn. The Board recommended ₹0.40 dividend per share and issued ₹25,000 lakhs NCDs at 8.15%. Audio recording of the April 28, 2026 analyst meet is available on the company website.

*this image is generated using AI for illustrative purposes only.
Canara HSBC Life Insurance Company Limited has released its audited financial results for the quarter and financial year ended March 31, 2026, pursuant to Regulation 33 and Regulation 52 read with Regulation 63(2) of SEBI Listing Regulations. The Board of Directors approved these results at their meeting held on April 28, 2026. Additionally, the company has made available the audio recording of the analyst meet discussion on these audited financial results conducted on April 28, 2026, which concluded at 8:30 pm IST.
Regulatory Compliance and Audit Process
The financial results were audited by joint statutory auditors Raj Har Gopal & Co. (Registration No. 002074N) and Brahmayya & Co. (Registration No. 000513S). Company Secretary and Compliance Officer Vatsala Sameer (Membership No: A14813) oversaw the regulatory filing process with digital signatures confirming submission authenticity on April 28, 2026 at 22:13:56 +05'30'.
| Exchange Details: | Information |
|---|---|
| NSE Symbol: | CANHLIFE |
| BSE Security Code: | 544583 |
| Equity ISIN: | INE01TY01017 |
| Debentures ISIN: | INE01TY08012 |
Financial Performance Highlights FY26
The company demonstrated strong performance across key financial metrics during FY26. The audited results showcase significant growth in core business parameters and enhanced profitability indicators.
| Financial Metrics: | FY26 | FY25 | Growth |
|---|---|---|---|
| Individual WPI: | ₹25,930 mn | ₹21,787 mn | +19% |
| Total APE: | ₹27,987 mn | ₹23,394 mn | +20% |
| VNB: | ₹6,273 mn | ₹4,461 mn | +41% |
| PAT: | ₹1,266 mn | ₹1,170 mn | +8% |
| Embedded Value: | ₹72,333 mn | ₹61,107 mn | +18% |
Share Capital and Dividend Declaration
As of March 31, 2026, the company has 950,000,000 issued, subscribed and paid-up equity shares with a face value of ₹10 each. The Board of Directors has recommended a final dividend of ₹0.40 per equity share for FY26, subject to shareholders' approval at the Annual General Meeting.
Debt Issuance and Capital Structure
During FY26, the company issued unsecured, rated, listed, subordinated, redeemable non-convertible debentures (NCDs) aggregating to ₹25,000 lakhs at a coupon rate of 8.15% per annum. The NCDs were allotted on March 13, 2026, and are redeemable at the end of 10 years with a call option for early redemption after 5 years. These NCDs have been rated "CRISIL AA+/Stable" by CRISIL and "CARE AA+/Stable" by CARE.
Market Position and Strategic Developments
Canara HSBC Life Insurance maintained its market share at 2.0% of the industry, with strong persistency ratios of 86.3% for 13th month policies. The company's VNB margin improved to 22.4% in FY26 from 19.1% in FY25, reflecting enhanced profitability and operational efficiency. The presentation highlighted the company's expansion in distribution channels, including the launch of its agency business model with ₹140 mn APE collected and approximately 500 distributors onboarded by March 2026.
Transparency and Accessibility
In accordance with IRDAI circular requirements on 'Public Disclosures by Insurers' dated September 30, 2021, the company will publish the financials on its official website at www.canarahsbclife.com not later than May 27, 2026. The audio recording of the analyst meet discussion on the audited financial results for Q4FY26 held on April 28, 2026 is now available on the company's website, ensuring stakeholder access to comprehensive financial information and strategic updates.
How will the expansion of Canara HSBC Life's agency business model beyond the initial 500 distributors impact market share growth in FY27?
What strategic initiatives might the company pursue with the ₹2,500 crore raised through NCDs to drive future growth?
Will the improved VNB margin of 22.4% be sustainable given increasing competition in the life insurance sector?
































